SCHEMBL8869433

SCHEMBL8869433

C[CH]C(=O)OC(c1ccccc1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.49
ESR2 Q92731 1/20 0.49
HCAR2 Q8TDS4 1/20 0.47
KMT2A Q03164 1/20 0.42
LMNA P02545 3/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.40
SRC P12931 1/20 0.40
MAPK1 P28482 1/20 0.39
KIF11 P52732 1/20 0.39
SRD5A2 P31213 1/20 0.39
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11221010 0.85 KDM4E (0.48) ESR1ESR2HCAR2KMT2ALMNA
SCHEMBL11156533 0.85 HCAR2 (0.53) ESR1ESR2HCAR2KMT2ALMNA
SCHEMBL8625297 0.83 HCAR2 (0.59) ESR1ESR2HCAR2KMT2ALMNA
SCHEMBL27534210 0.83 HCAR2 (0.59) ESR1ESR2HCAR2KMT2ALMNA
SCHEMBL8625307 0.83 HCAR2 (0.59) ESR1ESR2HCAR2KMT2ALMNA
SCHEMBL6966049 0.82 HCAR2 (0.69) HCAR2KMT2AALDH1A1CYP3A4CYP2D6
SCHEMBL10983709 0.82 ESR1 (0.50) ESR1ESR2HCAR2KMT2ALMNA
SCHEMBL29770346 0.81 ESR1 (0.46) ESR1ESR2HCAR2KMT2ALMNA
SCHEMBL27704799 0.80 HCAR2 (0.49) ESR1ESR2HCAR2KMT2ALMNA
SCHEMBL21843922 0.80 ESR1 (0.49) ESR1ESR2HCAR2KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5594132-A ANTIBIOTIC FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-01-14 US disclosed
US-5026695-A Gram negative-gram positive microbiocides, oral adminis tration FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-06-25 US disclosed
US-4904652-A 7-acylamino-3-substituted cephalosporanic acid derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-02-27 US disclosed
EP-0029557-B1 7-ACYLAMINO-3-SUBSTITUTED CEPHALOSPORANIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-03-13 EP disclosed
US-4464369-A CEPHALOSPORINS, ANTIMICROBIALS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-08-07 US disclosed
US-4462999-A CEPHALOSPORINS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-07-31 US disclosed
EP-0108977-A2 Starting compounds for preparing 7-acylamino-3-substituted cephalosporanic acid derivatives and process for their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-05-23 EP disclosed
US-4409215-A BACTERICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-10-11 US disclosed
EP-0088385-A2 7-Acylamino-3-cephem-4-carboxylic acid derivatives, processes for the preparation of the same and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-09-14 EP disclosed
EP-0029557-A2 7-Acylamino-3-substituted cephalosporanic acid derivatives, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-06-03 EP disclosed
US-4097670-A ANTIBIOTICS E. R. SQUIBB & SONS, INC. (US) 1978-06-27 US disclosed